Actively Recruiting
Orofacial Pain Self-management: Personality Moderation Effect
Led by Fundación Universidad Católica de Valencia San Vicente Mártir · Updated on 2025-12-08
98
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this clinical trial is to study the effect of self-management on pain perception in patients with chronic orofacial pain and temporomandibular disorders (TMD) comparing it with the conventional treatment proposed by the TMD clinical practice guidelines. It also evaluates its effect on function and various psychosocial variables. As a secondary objective, this work proposes to study the variability between patients, in terms of personality factors, as moderators of the effect of treatment on pain perception. Including in the proposed statistical models certain covariates such as perception and/or coping with stress, anxiety and other psychosocial variables. This is a randomized clinical trial with two intervention groups and three measurement times (T0; pre-intervention, T1; post-5 weeks and T2; post-6 months). The experimental group will be applied a protocol based on self-management, which includes: therapeutic education, cognitive-behavioral tools, therapeutic exercise of the temporomandibular region, mind-body strategies and modifications of aspects related to lifestyle. The control group will carry out an intervention program based on the Clinical Practice Guidelines for the Management of Temporomandibular Joint Disorders. Therefore, using a set of tools based on therapeutic education, cognitive-behavioral tools for bruxism and other parafunctional habits, temporomandibular region exercises and manual therapy.
CONDITIONS
Official Title
Orofacial Pain Self-management: Personality Moderation Effect
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The patient presents TMDs diagnosed according to the CD/TMD classification.
- Age between 18 and 65.
- Presence of pain in mandibular, temporal, facial, peri-auricular and/or auricular regions.
- Presence of chronic orofacial pain. Defined by the ICD-11 as orofacial pain or headache that occurs for more than two hours a day for 50% of the days of the last three months.
- Orofacial pain is related to TMDs according to the International Classification of Headaches.
- Moderate pain intensity, corresponding to a weekly average of at least 30 mm on a 100 mm VAS (validated representation of moderate pain on the VAS scale = 31-54 mm)
You will not qualify if you...
- Concomitant rheumatic systemic pathologies.
- History of trauma or recent surgical intervention in the head, face, neck or chest.
- Presence of intraoral infections or odontogenic pain.
- Headache of neuropathic origin (trigeminal neuralgia, Arnold neuralgia, etc.).
- Being receiving therapy (except rescue pharmacological therapy) for this disorder or pain.
- Cognitive impairment that prevents the follow-up of an educational program (determined through the MoCA questionnaire)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Catholic Univerity of Valencia
Valencia, Valencia, Spain, 46001
Actively Recruiting
Research Team
M
Marta M Martínez-Soler, Physiotherapist
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here